Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory McCrimmon

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Neuroendocrinology|September 15, 2012
Hypoglycaemia: exercise for the brain?Michael Ashford, Craig Beall, Rory McCrimmon
Touchreviews in Endocrinology|January 25, 2023
Advances and Emerging Therapies in the Treatment of Non-alcoholic SteatohepatitisPaul N Brennan, John F Dillon, Rory McCrimmon
BMC Cardiovascular Disorders|August 25, 2017
Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled studyAlexander J M Brown, Chim Lang, Rory McCrimmon, et al.
Diabetologia|October 28, 2017
Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012-2014): a population-based observational studyJeremy Walker, Helen Colhoun, Shona Livingstone, et al.
European Heart Journal|June 25, 2020
A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trialAlexander J M Brown, Stephen Gandy, Rory McCrimmon, et al.
Diabetes Care|October 26, 2022
Using Data to Improve the Management of Diabetes: The Tayside ExperienceMoneeza K Siddiqui, Christopher Hall, Scott G Cunningham, et al.
Diabetologia|September 2, 2018
Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational studyThenmalar Vadiveloo, William Jeffcoate, Peter T Donnan, et al.
Diabetologia|February 12, 2015
Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in ScotlandMuhammad Omar Malik, L Govan, John R Petrie, et al.
Diabetes Care|November 24, 2017
Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital AdmissionSarah H Wild, Jeremy J Walker, Joanne R Morling, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 10, 2012
Hypothalamic Fkbp51 is induced by fasting, and elevated hypothalamic expression promotes obese phenotypesLinda Yang, Fumiko Isoda, Kelvin Yen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Neuroendocrinology|September 15, 2012
Hypoglycaemia: exercise for the brain?Michael Ashford, Craig Beall, Rory McCrimmon
Touchreviews in Endocrinology|January 25, 2023
Advances and Emerging Therapies in the Treatment of Non-alcoholic SteatohepatitisPaul N Brennan, John F Dillon, Rory McCrimmon
BMC Cardiovascular Disorders|August 25, 2017
Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled studyAlexander J M Brown, Chim Lang, Rory McCrimmon, et al.
Diabetologia|October 28, 2017
Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012-2014): a population-based observational studyJeremy Walker, Helen Colhoun, Shona Livingstone, et al.
European Heart Journal|June 25, 2020
A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trialAlexander J M Brown, Stephen Gandy, Rory McCrimmon, et al.
Diabetes Care|October 26, 2022
Using Data to Improve the Management of Diabetes: The Tayside ExperienceMoneeza K Siddiqui, Christopher Hall, Scott G Cunningham, et al.
Diabetologia|September 2, 2018
Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational studyThenmalar Vadiveloo, William Jeffcoate, Peter T Donnan, et al.
Diabetologia|February 12, 2015
Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in ScotlandMuhammad Omar Malik, L Govan, John R Petrie, et al.
Diabetes Care|November 24, 2017
Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital AdmissionSarah H Wild, Jeremy J Walker, Joanne R Morling, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 10, 2012
Hypothalamic Fkbp51 is induced by fasting, and elevated hypothalamic expression promotes obese phenotypesLinda Yang, Fumiko Isoda, Kelvin Yen, et al.
Pageof 2